Electrical Inhibition (EI): A Preliminary Study To Inhibit Preterm Labor And Preterm Birth

NCT ID: NCT02569216

Last Updated: 2017-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-09

Study Completion Date

2016-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An electrical-inhibition (EI) uterine pacemaker device similar to an electrical heart pacemaker delivers a weak electrical current to the human uterus during active preterm labor to rapidly and safely inhibit the unwanted premature uterine contractions and possibly a preterm birth.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Electrical intervention (EI) uses bipolar, constant-current (1-20 mA), square-wave pulses in 20% duty cycles. Women in active preterm labor have an electrode catheter placed into the posterior fornix of the vaginal canal. The EI current is given up to 80 minutes while monitoring tocodynamometric (toco) contractions and adjunct electrohysterographic (EHG) activity while continuously monitoring maternal vital signs, fetal heart rate and electrocardiogram (fECG). The study includes a pre-EI control period (C1); the EI period, when a 10-second current burst is delivered only during a contraction; and a post-EI control period (C2). The whole study will take a maximum of two hours.

The uterine toco contraction frequency and adjunct EHG electrical activity are analyzed for changes caused by EI. Changes in maternal vital signs, fetal heart rate and fECG will determine EI side-effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Birth Premature Labor

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Electrical Inhibition Preterm Birth Premature Birth Preterm Labor Premature Labor tocolytic uterus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electrical Inhibition (EI) intervention

Electrical Inhibition (EI) uterine pacemaker is activated only when there is a preterm uterine contraction. The EI uterine pacemaker delivers a 1-15mA (20mA maximum) constant direct current for only 2 seconds only while there is a preterm uterine contraction.

Group Type EXPERIMENTAL

Electrical Inhibition (EI)

Intervention Type DEVICE

constant direct current 1-20mA transvaginal 10 second bursts only when needed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical Inhibition (EI)

constant direct current 1-20mA transvaginal 10 second bursts only when needed

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 24 to 34 weeks pregnant with a singleton gestation;
* in preterm labor as defined by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics,78 as follows:

* persistent uterine contractions (4 every 20 minutes or 8 every 60 minutes)
* And any one or more of the following:

* Documented cervical change
* \> 1cm cervical dilatation and progressing
* \> 80% cervical effacement
* anticipate a normal spontaneous vaginal delivery (NSVD).
* at least 18 years of age
* signed a written Informed Consent Document
* willing and able to comply with study requirements

Exclusion Criteria

* severe preeclampsia
* severe abruption placenta
* rupture of amniotic membranes
* frank chorioamnionitis
* fetal death
* fetal anomaly incompatible with life
* severe fetal growth restriction (EFW \<5%)
* mature fetal lung studies
* maternal cardiac arrhythmias
* a permanent cardiac pacemaker
* a fetal cardiac arrhythmia
* contraindication for tocolysis
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeffrey Karsdon, M.D.

Role: STUDY_DIRECTOR

New York University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York University Hospital

Manhattan, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Karsdon J, Garfield RE, Shi SQ, Maner W, Saade G. Electrical inhibition of preterm birth: inhibition of uterine contractility in the rabbit and pup births in the rat. Am J Obstet Gynecol. 2005 Dec;193(6):1986-93. doi: 10.1016/j.ajog.2005.05.009.

Reference Type RESULT
PMID: 16325601 (View on PubMed)

Karsdon J, El Daouk M, Huang WM, Ashmead GG. Electrical pacemaker as a safe and feasible method for decreasing the uterine contractions of human preterm labor. J Perinat Med. 2012 Nov;40(6):697-700. doi: 10.1515/jpm-2012-0136.

Reference Type RESULT
PMID: 23089601 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

G080036

Identifier Type: OTHER

Identifier Source: secondary_id

15-00553

Identifier Type: -

Identifier Source: org_study_id